162 related articles for article (PubMed ID: 14691303)
1. Activated proliferation of B-cell lymphomas/leukemias with the SHP1 gene silencing by aberrant CpG methylation.
Koyama M; Oka T; Ouchida M; Nakatani Y; Nishiuchi R; Yoshino T; Hayashi K; Akagi T; Seino Y
Lab Invest; 2003 Dec; 83(12):1849-58. PubMed ID: 14691303
[TBL] [Abstract][Full Text] [Related]
2. Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas.
Oka T; Ouchida M; Koyama M; Ogama Y; Takada S; Nakatani Y; Tanaka T; Yoshino T; Hayashi K; Ohara N; Kondo E; Takahashi K; Tsuchiyama J; Tanimoto M; Shimizu K; Akagi T
Cancer Res; 2002 Nov; 62(22):6390-4. PubMed ID: 12438221
[TBL] [Abstract][Full Text] [Related]
3. Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia.
Rossi D; Capello D; Gloghini A; Franceschetti S; Paulli M; Bhatia K; Saglio G; Vitolo U; Pileri SA; Esteller M; Carbone A; Gaidano G
Haematologica; 2004 Feb; 89(2):154-64. PubMed ID: 15003890
[TBL] [Abstract][Full Text] [Related]
4. [Recent progress in the protein-tyrosine phosphatase SHP1 gene: the significant correlation of the SHP1 gene silencing with the onset of lymphomas/leukemias].
Oka T; Ouchida M
Nihon Rinsho; 2003 Nov; 61(11):2025-32. PubMed ID: 14619449
[TBL] [Abstract][Full Text] [Related]
5. [Significance of expression and promoter methylation of LITAF gene in B-cell lymphoma].
Wang J; Shi Y; Wang L; Ren G; Bai Y; Shi H; Zhang X; Jiang X; Zhou R
Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):516-21. PubMed ID: 25346120
[TBL] [Abstract][Full Text] [Related]
6. Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors.
Reddy J; Shivapurkar N; Takahashi T; Parikh G; Stastny V; Echebiri C; Crumrine K; Zöchbauer-Müller S; Drach J; Zheng Y; Feng Z; Kroft SH; McKenna RW; Gazdar AF
Oncogene; 2005 Jan; 24(4):732-6. PubMed ID: 15580314
[TBL] [Abstract][Full Text] [Related]
7. Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias : combination analysis with cDNA expression array and tissue microarray.
Oka T; Yoshino T; Hayashi K; Ohara N; Nakanishi T; Yamaai Y; Hiraki A; Sogawa CA; Kondo E; Teramoto N; Takahashi K; Tsuchiyama J; Akagi T
Am J Pathol; 2001 Oct; 159(4):1495-505. PubMed ID: 11583976
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
9. Prevalent hyper-methylation of the CDH13 gene promoter in malignant B cell lymphomas.
Ogama Y; Ouchida M; Yoshino T; Ito S; Takimoto H; Shiote Y; Ishimaru F; Harada M; Tanimoto M; Shimizu K
Int J Oncol; 2004 Sep; 25(3):685-91. PubMed ID: 15289870
[TBL] [Abstract][Full Text] [Related]
10. STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes.
Zhang Q; Wang HY; Marzec M; Raghunath PN; Nagasawa T; Wasik MA
Proc Natl Acad Sci U S A; 2005 May; 102(19):6948-53. PubMed ID: 15870198
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation and anti-tumorigenic effects of SH2-containing protein tyrosine phosphatase 1 (SHP1) in human gastric cancer cells.
Joo MK; Park JJ; Yoo HS; Lee BJ; Chun HJ; Lee SW; Bak YT
Tumour Biol; 2016 Apr; 37(4):4603-12. PubMed ID: 26508024
[TBL] [Abstract][Full Text] [Related]
12. Restoration of shp1 expression by 5-AZA-2'-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma.
Han Y; Amin HM; Frantz C; Franko B; Lee J; Lin Q; Lai R
Leukemia; 2006 Sep; 20(9):1602-9. PubMed ID: 16871283
[TBL] [Abstract][Full Text] [Related]
13. Methylated alteration of SHP1 complements mutation of JAK2 tyrosine kinase in patients with myeloproliferative neoplasm.
Yang JJ; Chen H; Zheng XQ; Li HY; Wu JB; Tang LY; Gao SM
Asian Pac J Cancer Prev; 2015; 16(6):2219-25. PubMed ID: 25824741
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
[TBL] [Abstract][Full Text] [Related]
15. Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphoma.
Sato H; Oka T; Shinnou Y; Kondo T; Washio K; Takano M; Takata K; Morito T; Huang X; Tamura M; Kitamura Y; Ohara N; Ouchida M; Ohshima K; Shimizu K; Tanimoto M; Takahashi K; Matsuoka M; Utsunomiya A; Yoshino T
Am J Pathol; 2010 Jan; 176(1):402-15. PubMed ID: 20019193
[TBL] [Abstract][Full Text] [Related]
16. Methylation of SHP1 gene and loss of SHP1 protein expression are frequent in systemic anaplastic large cell lymphoma.
Khoury JD; Rassidakis GZ; Medeiros LJ; Amin HM; Lai R
Blood; 2004 Sep; 104(5):1580-1. PubMed ID: 15317731
[No Abstract] [Full Text] [Related]
17. Plasma DNA methylation of p16 and shp1 in patients with B cell non-Hodgkin lymphoma.
Ding K; Chen X; Wang Y; Liu H; Song W; Li L; Wang G; Song J; Shao Z; Fu R
Int J Clin Oncol; 2017 Jun; 22(3):585-592. PubMed ID: 28210822
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas.
Wang Z; Li L; Su X; Gao Z; Srivastava G; Murray PG; Ambinder R; Tao Q
J Transl Med; 2012 Oct; 10():209. PubMed ID: 23050586
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy.
Zhang MY; Calin GA; Yuen KS; Jin DY; Chim CS
Clin Epigenetics; 2020 Oct; 12(1):150. PubMed ID: 33076962
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic down-regulation of death-associated protein kinase in lung cancers.
Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF
Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
